BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 21310372)

  • 1. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Grygier M; Araszkiewicz A; Lesiak M; Janus M; Kowal J; Skorupski W; Pyda M; Mitkowski P; Grajek S
    Am J Cardiol; 2011 Apr; 107(8):1131-5. PubMed ID: 21310372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of new method of intracoronary adenosine injection during primary percutaneous coronary intervention on microvascular reperfusion injury - clinical outcome and 1-year follow-up.
    Grygier M; Araszkiewicz A; Lesiak M; Grajek S
    Cardiology; 2013; 124(3):199-206. PubMed ID: 23548697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction.
    Desmet W; Bogaert J; Dubois C; Sinnaeve P; Adriaenssens T; Pappas C; Ganame J; Dymarkowski S; Janssens S; Belmans A; Van de Werf F
    Eur Heart J; 2011 Apr; 32(7):867-77. PubMed ID: 21196444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
    Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
    Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study.
    Stoel MG; Marques KM; de Cock CC; Bronzwaer JG; von Birgelen C; Zijlstra F
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):283-9. PubMed ID: 17985384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
    Fokkema ML; Vlaar PJ; Vogelzang M; Gu YL; Kampinga MA; de Smet BJ; Jessurun GA; Anthonio RL; van den Heuvel AF; Tan ES; Zijlstra F
    Circ Cardiovasc Interv; 2009 Aug; 2(4):323-9. PubMed ID: 20031735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
    Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
    Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
    Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
    Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
    Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
    Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction.
    Claeys MJ; Bosmans J; De Ceuninck M; Beunis A; Vergauwen W; Vorlat A; Vrints CJ
    Am J Cardiol; 2004 Jul; 94(1):9-13. PubMed ID: 15219500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
    J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Kırma C; Erkol A; Pala S; Oduncu V; Dündar C; İzgi A; Tigen K; Gibson CM
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):59-67. PubMed ID: 21523892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Hahn JY; Kim HJ; Choi YJ; Jo SH; Kim HJ; Lee S; Ahn KJ; Song YB; Choi JH; Choi SH; Choi YJ; Lee KH; Lee SH; Gwon HC
    Am Heart J; 2011 Dec; 162(6):1026-33. PubMed ID: 22137076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.